Marc Fransen
- Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders 15
- Molecular Biology top 1%
- Peroxisome Proliferator-Activated Receptors 93
- RNA Research and Splicing 19
- RNA modifications and cancer 12
- Physiology top 1%
- Adipose Tissue and Metabolism 19
- Adenosine and Purinergic Signaling 12
- Biochemistry top 1%
- Immunology top 5%
- interferon and immune responses 13
-
- Cancer, Hypoxia, and Metabolism 12
- Co-authors
- Paul P. Van VeldhovenMarcus NordgrenCelien LismontChantal BreesGuy P. MannaertsOksana ApanasetsBo WangJorge E. Azevedo
In The Last Decade
Marc Fransen
110 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Clinical Biochemistry 598
- Molecular Biology 5.1k
- Physiology 233
- Biochemistry 363
- Immunology 871
Countries citing papers authored by Marc Fransen
This map shows the geographic impact of Marc Fransen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Fransen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Fransen more than expected).
Fields of papers citing papers by Marc Fransen
This network shows the impact of papers produced by Marc Fransen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Fransen. The network helps show where Marc Fransen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc Fransen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 12 | |
| 6 | 2022 | 5 | |
| 7 | 2018 | 34 | |
| 8 | 2018 | 60 | |
| 9 | 2017 | 30 | |
| 10 | 2015 | 30 | |
| 11 | 2014 | 64 | |
| 12 | 2011 | 164 | |
| 13 | 2009 | 13 | |
| 14 | 2009 | 22 | |
| 15 | 2006 | 47 | |
| 16 | 2006 | 104 | |
| 17 | 2004 | 62 | |
| 18 | 1996 | 28 | |
| 19 | 1995 | 160 | |
| 20 | 1994 | 7 |
About Marc Fransen
Marc Fransen is a scholar working on Physiology, Clinical Biochemistry and Molecular Biology, having authored 111 papers that have together received 6.2k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (93 papers), Adipose Tissue and Metabolism (19 papers), RNA Research and Splicing (19 papers), Metabolism and Genetic Disorders (15 papers), interferon and immune responses (13 papers), Cancer, Hypoxia, and Metabolism (12 papers), Adenosine and Purinergic Signaling (12 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Clinical Biochemistry (598 citations), Molecular Biology (5.1k citations) and Physiology (233 citations). Marc Fransen has collaborated with scholars based in Belgium, Portugal and Germany. Frequent co-authors include Paul P. Van Veldhoven, Marcus Nordgren, Celien Lismont, Chantal Brees, Guy P. Mannaerts, Oksana Apanasets, Bo Wang, Jorge E. Azevedo, Stanley R. Terlecky and Paul A. Walton. Their work appears in journals such as Journal of Biological Chemistry, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Biochemical Journal, Frontiers in Cell and Developmental Biology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.